AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21610557 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume ultrasound-guided ankle block
Number of subjects: 72
Study 21610557 — intervention group
Group type: COMPARATOR
Intervention: Conventional-volume surface landmark technique
Number of subjects: 72
Study 18496477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (synthetic delta9-THC)
Number of subjects: 1
Study 16680438 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty without patellar resurfacing
Number of subjects: 111
Study 12803865 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (CQ) alone (30 mg/kg base given over 3 days)
Number of subjects: 145
Study 12803865 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine plus ketotifen (CQK) (0.25 mg at presentation followed by 0.125 mg/kg every 8 h for 5 days)
Number of subjects: 145
Study 12803865 — intervention group
Group type: EXPERIMENTAL
Intervention: Retreatment with CQK
Number of subjects: 145
Study 12803865 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine plus pyrimethamine-sulfadoxine
Number of subjects: 145
Study 12803865 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (CQ) alone
Number of subjects: 145
Study 12803865 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine plus ketotifen (CQK)
Number of subjects: 145
Study 11147611 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive screening with chest X-rays and sputum cytology tests every 4 months for 6 years
Number of subjects: 0
Study 11147611 — intervention group
Group type: COMPARATOR
Intervention: Control group advised to undergo chest X-rays and sputum cytology tests yearly
Number of subjects: 0
Study 8851579 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% fat emulsion formulation (Intralipid; 20% IL)
Number of subjects: 16
Study 8851579 — intervention group
Group type: COMPARATOR
Intervention: 5% dextrose (glucose) (5% D) solution
Number of subjects: 16
Study 1471513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fracture reduction
Number of subjects: 149
Study 1471513 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiographic signs (small head fragment, comminution of the calcar femorale, varus angulation of the head)
Number of subjects: 149
Study 1471513 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative predictive signs
Number of subjects: 149
Study 6720619 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement (1 g/day for 8 days)
Number of subjects: 14
Study 30267357 — intervention group
Group type: EXPERIMENTAL
Intervention: Local glucocorticoid (GC) injection combined with local anaesthetic
Number of subjects: 46
Study 30267357 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (placebo)
Number of subjects: 46
Study 30272098 — intervention group
Group type: EXPERIMENTAL
Intervention: High-speed resistance exercise training (n=22)
Number of subjects: 45
Study 30272098 — intervention group
Group type: COMPARATOR
Intervention: Control group (balance and band stretching, n=23)
Number of subjects: 45
Study 28082816 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCFM (low-dose)
Number of subjects: 340
Study 28082816 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCFM (high-dose)
Number of subjects: 340
Study 28082816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 25257294 — intervention group
Group type: EXPERIMENTAL
Intervention: Context aware experiential sampling in social settings (pub, bar, club)
Number of subjects: 72
Study 25257294 — intervention group
Group type: EXPERIMENTAL
Intervention: Current alcohol consumption
Number of subjects: 72
Study 22859747 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular disease
Number of subjects: 837
Study 22859747 — intervention group
Group type: COMPARATOR
Intervention: Standard survival analysis
Number of subjects: 837
Study 20132649 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (mint and fruit varieties)
Number of subjects: 133
Study 20132649 — intervention group
Group type: COMPARATOR
Intervention: No chewing gum (baseline condition)
Number of subjects: 133
Study 17322450 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-7
Number of subjects: 40
Study 17322450 — intervention group
Group type: COMPARATOR
Intervention: Control (no rhBMP-7)
Number of subjects: 40
Study 16351593 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril and ultra filtration
Number of subjects: 80
Study 16351593 — intervention group
Group type: COMPARATOR
Intervention: Ultra filtration (control group)
Number of subjects: 80
Study 11867886 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplements (folic acid 2 mg, B(6) 25 mg, B(12) 500 mug)
Number of subjects: 8000
Study 11867886 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 8000
Study 11210402 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride (2.4 g)
Number of subjects: 60
Study 11210402 — intervention group
Group type: COMPARATOR
Intervention: No sevelamer (control)
Number of subjects: 60
Study 9743509 — intervention group
Group type: COMPARATOR
Intervention: β-blockers
Number of subjects: 3023
Study 7949264 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative fibrin sealing (Group A, 43 subjects)
Number of subjects: 97
Study 7949264 — intervention group
Group type: COMPARATOR
Intervention: No fibrin sealing (Group B, 54 patients)
Number of subjects: 97
Study 3109445 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 36
Study 3109445 — intervention group
Group type: COMPARATOR
Intervention: Vegetable oil (placebo)
Number of subjects: 36
Study 29044532 — intervention group
Group type: EXPERIMENTAL
Intervention: Duct-to-mucosa technique
Number of subjects: 193
Study 29044532 — intervention group
Group type: COMPARATOR
Intervention: Dunking technique
Number of subjects: 193
Study 28446223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT) programme included in social and emotional provision.
Number of subjects: 5700
Study 28446223 — intervention group
Group type: COMPARATOR
Intervention: Normal school provision (control group).
Number of subjects: 5700
Study 26181147 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapeutic exercises
Number of subjects: 2
Study 26181147 — intervention group
Group type: COMPARATOR
Intervention: Physically inactive
Number of subjects: 2
Study 23952805 — intervention group
Group type: EXPERIMENTAL
Intervention: iLarynx software
Number of subjects: 20
Study 23952805 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 20
Study 21062778 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-point cardiac troponin I (cTnI) sampling at 24 or 48 hours
Number of subjects: 132
Study 21062778 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-point cardiac troponin I (cTnI)
Number of subjects: 132
Study 18430053 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day) for 4 months
Number of subjects: 36
Study 18430053 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin (10 mg/day) for 4 months
Number of subjects: 36
Study 18430053 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 36
Study 16670247 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg memantine twice a day
Number of subjects: 404
Study 16670247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study 15030296 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with ACE inhibitors or angiotensin II receptor antagonists and diuretics
Number of subjects: 0
Study 15030296 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors or angiotensin II receptor antagonists alone
Number of subjects: 0
Study 15030296 — intervention group
Group type: COMPARATOR
Intervention: Diuretics alone
Number of subjects: 0
Study 10663453 — intervention group
Group type: COMPARATOR
Intervention: Lariam (reference formulation)
Number of subjects: 29
Study 10663453 — intervention group
Group type: EXPERIMENTAL
Intervention: Mephaquin 100 Lactab
Number of subjects: 29
Study 10663453 — intervention group
Group type: EXPERIMENTAL
Intervention: Eloquin-250
Number of subjects: 29
Study 8644658 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged balloon inflations (3 to 5 inflations of 3 to 5 minutes each; n = 149)
Number of subjects: 289
Study 8644658 — intervention group
Group type: COMPARATOR
Intervention: Standard balloon inflations (3 to 5 inflations < or = 1 minute each; n = 161)
Number of subjects: 289
Study 8644658 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 289
Study 1586398 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 2182
Study 1586398 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 2182
Study 1586398 — intervention group
Group type: COMPARATOR
Intervention: Stress management
Number of subjects: 2182
Study 1586398 — intervention group
Group type: COMPARATOR
Intervention: Nutritional supplements (calcium, magnesium, potassium, fish oil)
Number of subjects: 2182
Study 30796686 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-balloon enteroscopy with a transparent cap
Number of subjects: 90
Study 30796686 — intervention group
Group type: COMPARATOR
Intervention: Single-balloon enteroscopy without a transparent cap
Number of subjects: 90
Study 29448886 — intervention group
Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 26
Study 29448886 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study 25754214 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics (Lactobacillus, Bifidobacterium, and fructo‐oligosaccharide)
Number of subjects: 220
Study 25754214 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 220
Study 24500432 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB-FA
Number of subjects: 39
Study 24500432 — intervention group
Group type: COMPARATOR
Intervention: CWI
Number of subjects: 39
Study 24500432 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB-FA-CWI
Number of subjects: 39
Study 24500432 — intervention group
Group type: COMPARATOR
Intervention: Placebo-CWI
Number of subjects: 39
Study 24500432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 22187126 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense sequential epirubicin 110 mg/m(2) and paclitaxel 250 mg/m(2)
Number of subjects: 1121
Study 22187126 — intervention group
Group type: COMPARATOR
Intervention: Concurrent epirubicin 83 mg/m(2) and paclitaxel 187 mg/m(2)
Number of subjects: 1121
Study 20542391 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg naltrexone
Number of subjects: 172
Study 20542391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 17394081 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium polycarbophil (3 g/day) plus bifidobacterium (3 g/day)
Number of subjects: 21
Study 17394081 — intervention group
Group type: COMPARATOR
Intervention: Bifidobacterium (3 g/day)
Number of subjects: 21
Study 16295151 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Education Aimed at Toddlers (NEAT) intervention, comprising four nutrition lessons and structured reinforcements over 6 months
Number of subjects: 135
Study 16295151 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 135
Study 12087454 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cycles of cyclophosphamide, methotrexate and fluorouracil (CMF)
Number of subjects: 1024
Study 12087454 — intervention group
Group type: COMPARATOR
Intervention: Six cycles of cyclophosphamide, methotrexate and fluorouracil (CMF)
Number of subjects: 1024
Study 12087454 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cycles of CMF for patients at least 40 years old with oestrogen-receptor-positive tumours
Number of subjects: 1024
Study 12087454 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cycles of CMF for women less than 40 years old
Number of subjects: 1024
Study 12087454 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cycles of CMF for women with oestrogen-receptor-negative tumours
Number of subjects: 1024
Study 10215752 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous lenograstim (0.5, 2, 5, or 10 microg kg(‐1))
Number of subjects: 27
Study 10215752 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lenograstim (0.5, 2, 5, or 10 microg kg(‐1))
Number of subjects: 27
Study 10215752 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous lenograstim (5 microg kg(‐1))
Number of subjects: 27
Study 10215752 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lenograstim (5 microg kg(‐1))
Number of subjects: 27
Study 10215752 — intervention group
Group type: EXPERIMENTAL
Intervention: Both routes of lenograstim
Number of subjects: 27
Study 7891484 — intervention group
Group type: COMPARATOR
Intervention: D1 dissection
Number of subjects: 711
Study 7891484 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 dissection
Number of subjects: 711
Study 2170718 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microgram dose group
Number of subjects: 36
Study 2170718 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microgram dose group
Number of subjects: 36
Study 2170718 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 microgram dose group
Number of subjects: 36
Study 2170718 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study 374162 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllocontin Continus tablets
Number of subjects: 40
Study 374162 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Ventolin tablets and Phyllocontin tablets
Number of subjects: 40
Study 374162 — intervention group
Group type: COMPARATOR
Intervention: Ventolin tablets
Number of subjects: 40
Study 31318742 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported Functional Independence Measure (care recipient self-reported)
Number of subjects: 90
Study 31318742 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver self-reported Functional Independence Measure
Number of subjects: 90
Study 31318742 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluator rated Functional Independence Measure
Number of subjects: 90
Study 31318742 — intervention group
Group type: COMPARATOR
Intervention: Care recipient self-reported Functional Independence Measure
Number of subjects: 90
Study 27803006 — intervention group
Group type: EXPERIMENTAL
Intervention: Buparlisib with paclitaxel
Number of subjects: 416
Study 27803006 — intervention group
Group type: COMPARATOR
Intervention: Placebo with paclitaxel
Number of subjects: 416
Study 25525954 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric overload training (EOT)
Number of subjects: 20
Study 22374732 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week online support group intervention including moderated discussion forum and psycho-educational materials.
Number of subjects: 27
Study 22374732 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition.
Number of subjects: 27
Study 21318564 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (250 mg)
Number of subjects: 16
Study 21318564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19670959 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Care (GC)
Number of subjects: 904
Study 17895576 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelnidipine for 12 weeks
Number of subjects: 0
Study 17895576 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study 17895576 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C and E for 8 weeks
Number of subjects: 0
Study 15121119 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Anaesthesia (LA) CEA
Number of subjects: 176
Study 15121119 — intervention group
Group type: COMPARATOR
Intervention: General Anaesthesia (GA) CEA
Number of subjects: 176
Study 11219510 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic algorithm neural network assessment
Number of subjects: 20
Study 11219510 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative distance (Dr) assessment
Number of subjects: 20
Study 9240864 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase I and II trials
Number of subjects: 0
Study 9240864 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase III trials
Number of subjects: 0
Study 9240864 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethically impeccable study designs
Number of subjects: 0
Study 9240864 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide access to drugs
Number of subjects: 0
Study 7894910 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate blood samples stored longer than 1 hour
Number of subjects: 58
Study 7894910 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate blood samples stored on the cold for 24 hours
Number of subjects: 58
Study 7894910 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate blood samples adapted to room temperature after cold storage
Number of subjects: 58
Study 3473681 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 + 5 DAT
Number of subjects: 1000
Study 3473681 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 + 10 DAT
Number of subjects: 1000
Study 3473681 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation therapy (COAP or MAZE)
Number of subjects: 1000
Study 3473681 — intervention group
Group type: COMPARATOR
Intervention: Conventional doses of ara‐C
Number of subjects: 1000
Study 31634205 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal genetic variants as instruments (four independent variants)
Number of subjects: 0
Study 31634205 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulations of instrumental inequalities
Number of subjects: 0
Study 29019878 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Surgery (HS)
Number of subjects: 55
Study 29019878 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 55
Study 25172986 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention of information and communication (standard information about MRI scans and communication via intercom every 2 minutes)
Number of subjects: 33
Study 25172986 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 33
Study 25172986 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention of information and communication
Number of subjects: 33
Study 23344474 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent nocturnal hemodialysis
Number of subjects: 146
Study 23344474 — intervention group
Group type: COMPARATOR
Intervention: Control group (three-times-per-week hemodialysis)
Number of subjects: 146
Study 23344474 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent daily hemodialysis
Number of subjects: 146
Study 22333201 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d) for 12 weeks
Number of subjects: 76
Study 19480608 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 0
Study 17301099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum group (management strategy to minimise eosinophilic airway inflammation)
Number of subjects: 82
Study 17301099 — intervention group
Group type: COMPARATOR
Intervention: BTS group (traditional guidelines)
Number of subjects: 82
Study 17301099 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study 17301099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum group
Number of subjects: 82
Study 15675647 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus set in upper or lower display positions
Number of subjects: 0
Study 15675647 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus set in left, center, or right positions relative to response location
Number of subjects: 0
Study 15675647 — intervention group
Group type: EXPERIMENTAL
Intervention: Response location relative to stimulus display and body midline
Number of subjects: 0
Study 12577375 — intervention group
Group type: EXPERIMENTAL
Intervention: Ningxie Powder (NXP)
Number of subjects: 63
Study 12577375 — intervention group
Group type: COMPARATOR
Intervention: salicylazosulfapyridine (SASP)
Number of subjects: 63
Study 9802618 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant irradiation
Number of subjects: 356
Study 9802618 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 356
Study 9802618 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen therapy with no irradiation
Number of subjects: 356
Study 9802618 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant tamoxifen therapy with irradiation
Number of subjects: 356
Study 7984295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-tryptophan (low-TRP) drink
Number of subjects: 12
Study 2725871 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 1
Study 2725871 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 1
Study 2725871 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 1
Study 2725871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 29055130 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined coasting and cabergoline
Number of subjects: 300
Study 29055130 — intervention group
Group type: COMPARATOR
Intervention: Cabergoline alone
Number of subjects: 300
Study 29055130 — intervention group
Group type: COMPARATOR
Intervention: Coasting alone
Number of subjects: 300
Study 28552806 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-Helicobacter pylori concomitant therapy
Number of subjects: 0
Study 28552806 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Saccharomyces boulardii)
Number of subjects: 0
Study 28552806 — intervention group
Group type: COMPARATOR
Intervention: Eradication therapy without probiotics
Number of subjects: 0
Study 28552806 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic combination
Number of subjects: 0
Study 26596011 — intervention group
Group type: EXPERIMENTAL
Intervention: Postaurical injection of methylprednisolone, 40 mg/2 d for 14 d, combined with Ginkgo dipyidamolum and Alprostadil.
Number of subjects: 80
Study 26596011 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone, 1 mg/kg/d for 3 d, if effective, prolonging for another 2 d, combined with Ginkgo dipyidamolum and Alprostadil.
Number of subjects: 80